Clinical Study Comparing Two Models of a Travoprost Intraocular Implant



Status:Recruiting
Conditions:High Blood Pressure (Hypertension), Ocular
Therapuetic Areas:Cardiology / Vascular Diseases, Ophthalmology
Healthy:No
Age Range:18 - Any
Updated:3/10/2019
Start Date:August 2, 2018
End Date:June 2023
Contact:Kerry Stephens, OD
Email:kstephens@glaukos.com
Phone:949-481-8057

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Prospective, Randomized Phase III Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%

Phase III study to compare the safety and efficacy of intraocular implants containing
Travoprost at two different elution rates versus Timolol Maleate Ophthalmic Solution, 0.5%
(Timolol) in reducing elevated intraocular pressure in subjects with open angle glaucoma
(OAG) or ocular hypertension (OHT)

This is a prospective, randomized, double-masked, active-controlled, parallel-group,
multi-center trial comparing the efficacy and safety of the Model G2TR-063 Travoprost
Intraocular Implant and the Model G2TR-125 Travoprost Intraocular Implant to topical Timolol
in subjects with OAG or OHT. The staff who record key efficacy measures and the study
subjects will remain masked to study treatment.

Inclusion Criteria:

- Diagnosed with open-angle glaucoma or ocular hypertension

- C/D ratio ≤ 0.8

- Zero to two preoperative ocular hypotensive medications

Exclusion Criteria:

- Active corneal inflammation or edema

- Retinal disorders not associated with glaucoma
We found this trial at
1
site
Center for Sight
Las Vegas, Nevada 89145
Phone: 702-724-2020
?
mi
from
Las Vegas, NV
Click here to add this to my saved trials